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Abstract
Diffuse cutaneous leishmaniasis (DCL) is a rare clinical manifestation of leishmaniasis, characterized by an inefficient
parasite-specific cellular response and heavily parasitized macrophages. In Brazil, Leishmania (Leishmania) amazonensis is
the main species involved in DCL cases. In the experimental model, recognition of phosphatidylserine (PS) molecules
exposed on the surface of amastigotes forms of L. amazonensis inhibits the inflammatory response of infected macrophages
as a strategy to evade the host immune surveillance. In this study, we examined whether PS exposure on L. amazonensis
isolates from DCL patients operated as a parasite pathogenic factor and as a putative suppression mechanism of immune
response during the infection. Peritoneal macrophages from F1 mice (BALB/c6C57BL/6) were infected with different L.
amazonensis isolates from patients with localized cutaneous leishmaniasis (LCL) or DCL. DCL isolates showed higher PS
exposure than their counterparts from LCL patients. In addition, PS exposure was positively correlated with clinical
parameters of the human infection (number of lesions and time of disease) and with characteristics of the experimental
infection (macrophage infection and anti-inflammatory cytokine induction). Furthermore, parasites isolated from DCL
patients displayed an increased area in parasitophorous vacuoles (PV) when compared to those isolated from LCL patients.
Thus, this study shows for the first time that a parasite factor (exposed PS) might be associated with parasite survival/
persistence in macrophages and lesion exacerbation during the course of DCL, providing new insights regarding
pathogenic mechanism in this rare chronic disease.
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Introduction
American cutaneous leishmaniasis is a disease caused by
flagellated protozoa of the genus Leishmania. These organisms are
obligatory intracellular parasites in mammalian hosts where they
differentiate into amastigote forms, capable of proliferating inside
macrophages and disseminating the disease [1]. Cutaneous
leishmaniasis presents a wide spectrum of clinical manifestation
in humans, varying from self-healing localized cutaneous leish-
maniasis (LCL) to more severe forms such as mucocutaneous
leishmaniasis (MCL) and diffuse cutaneous leishmaniasis (DCL)
[2]. These different clinical forms depend mainly on the infecting
Leishmania and host cell-mediated immune responses [3]. In Brazil,
L. amazonensis infection can cause two distinct clinical forms of
cutaneous leishmaniasis: LCL and DCL [2,4]. While the clinical
course of LCL is well characterized, the molecular mechanisms
underlying DCL pathogenesis are still unclear. DCL is a rare
clinical manifestation and is characterized by the appearance of
several nonulcerated nodular skin lesions, uncontrolled parasite
proliferation, resistance to most therapeutic strategies and absence
or reduction of the cellular immune response against parasite
antigens [2,3]. Disseminated leishmaniasis (DL) is another rare
clinical presentation of cutaneous leishmaniasis and might be
confused with DCL since both have multiple lesions. However, the
former is clinically characterized by the predominance of papules
and acneiform type of lesions and high frequency of mucosal
involvement. Additionally, DL patients show inhibition of the cell-
mediated immune mechanisms, resulting in negative responses of
the leishmanin skin test (LST) as well as the lymphocyte
proliferation assay, but different from DCL, these patients have
cellular immune responses totally restored with the conventional
antimony therapy [5].
Phosphatidylserine (PS) is a phospholipid usually entrapped in
the inner leaflet of the plasma membrane which, in some cases, is
translocated to the outer cell surface [6]. During apoptotic cell
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recognition, leading to engulfment of the target cell and triggering
the alternative activation of the phagocyte, characterized by
elevated TGF-b1 and IL-10 production [7,8]. Amastigote forms of
L. amazonensis take advantage of exposed PS during the host cell
infection inducing an anti-inflammatory response by macrophages
and dendritic cells (DC). This creates a permissive environment for
growth and dissemination [9] without necessarily progressing to
apoptotic death in a mechanism called "apoptotic mimicry"
[8,10]. Pathogens such as Toxoplasma gondii, Trypanosoma cruzi, and
vaccinia virus can also take advantage of PS recognition on their
surface to induce an anti-inflammatory response and to inhibit
microbicidal mechanism in order to establish infection in their
respective hosts [11–13].
In addition, PS exposure on the surface of Leishmania
promastigotes, as a consequence of apoptotic death due to nutrient
deprivation, has been implicated as an important virulence factor
in the establishment of infection by this parasite form. Van
Zandbergen et al.[14] have showed that presence of apoptotic
promastigotes of L. major, in an altruistic behavior, allows the
intracellular survival of viable parasites. Alongside, our group
showed that PS positive L. amazonensis promastigotes are present in
the sand fly gut, being part of the infective inoculums in natural
infections [15]. In this work, we examined whether PS exposure
on L. amazonensis parasites, isolated from DCL lesions, is a possible
mechanism of host immune suppression, thus playing a role in the
pathogenesis of this chronic form of leishmaniasis.
Materials and Methods
Parasite isolates
Parasites were obtained by puncture and aspiration after
previous asepsis and anesthesia of nodular lesions from DCL
patients and of border ulcerated from LCL patients. Parasite
strains were maintained in cryopreservation stock tanks since the
time of isolation. L. (L.) amazonensis isolates from LCL (n=5) or
DCL (n=7) patients were defrosted and cultivated in tubes with
biphasic medium Novy-MacNeal-Nicolle (NNN), consisting of
rabbit blood agar overlaid with Schneider’s insect medium (Sigma
Aldrich) pH 7.2 supplemented with 10% heat inactivated fetal
bovine serum (FBS-Gibco) and 1% antibiotic (Gibco). Parasite
isolates were expanded in vitro in complete Schneider medium,
pH 7.2, at 25uC until they reached the stationary phase. Following
expansion, aliquots of different strains of L. amazonensis were
cryopreserved in complete RPMI medium containing 10% FBS
(Gibco) and 1% DMSO until the moment of use and were not
inoculated in animal during the study.
A total of 14 strains were used in this study (Table 1). All isolates
used in these experiments were confirmed as L. amazonensis species
by Multilocus Electrophoresis of Enzymes (MLEE) analysis as
previously described [16]. This analysis was performed by
Leishmania Collection of the Oswaldo Cruz Institute (CLIOC),
FIOCRUZ, Rio de Janeiro, Brazil. The M2269 (MHOM/BR/
1973/M2269) World Health Organization (WHO) reference
strain was included in this study. As a control, we also used the
LV79 (MPRO/BR/72/M 1841-LV-79) strain that was originally
isolated from a case of LCL of primate, since its PS exposure
mechanism have been well characterized [9].
Epidemiological and clinical evaluations
Clinical and epidemiological characteristics of the patients with
LCL and DCL are presented in Table 2. DCL patient’s data were
obtained between 1980 and 1990 [2] and were studied at the
University of Bahia Hospital and in the Hospital dos Servidores do
Estado do Maranha ˜o, a state located in the Northeast of Brazil
and were followed by Dr. Jackson Costa [2]. All DCL patients
were diagnosed following previously described criteria [3,17].
DCL patients presented prolonged natural history of their disease,
negative response to leishmanin skin test (LST), intense number of
parasitised macrophages, multiple nodular lesions all over the skin
and chronic evolution of the disease, with several remissions. LCL
patients were from State of Bahia, Brazil and were followed by Dr.
Aldina Barral. Individuals with LCL presented a typical skin ulcer,
positive skin test response to leishmanin (Montenegro test),
duration of disease up to six months and presence of single or
few ulcerated lesions [2].
Written informed consent was obtained from all participants or
legal guardians. All clinical investigations were conducted accord-
ing to the principles expressed in the Declaration of Helsinki. The
project was approved by the institutional review board from
Centro de Pesquisas Gonc ¸alo Moniz-FIOCRUZ/BA and Federal
University of Maranha ˜o.
Mice
F1 (BALB/c x C57Bl/6) mice, age 6–8 weeks, were obtained
from the animal facility of Research Coordination at the National
Institute of Cancer (INCa- RJ, Brazil) or from Harlan Sprague
Dawley (Indianapolis, IN, USA). This study was carried out in
strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Health. All experimental procedures were approved and conduct-
ed according to the Brazilian Committee for Animal Experimen-
tation (COBEA, Permit Number: L-036/08) and by Committee
on the Ethics of Animal Experiments of the University of Texas
Medical Branch, Galveston, TX (Permit Number: 9803016A).
Surgery was performed under sodium pentobarbital anesthesia,
and efforts were made to minimize mouse suffering.
Macrophage infection
Thioglycollate-elicited peritoneal macrophages collected from
F1 mice were plated and non-adherent cells were removed by
Table 1. Leishmania amazonensis isolates used in this study.
Number Strain International Code (*) Origin Pathology
1 BA 106 MHOM/BR/1986/BA106 BA DCL
2 BA 199 MHOM/BR/1989/BA199 MA DCL
3 BA 276 MHOM/BR/1989/BA276 MA DCL
4 BA 336 MHOM/BR/1990/BA336 MA DCL
5 BA 700 MHOM/BR/1997/BA700 MA DCL
6 BA 760 MHOM/BR/1999/BA760 MA DCL
7 BA 820 MHOM/BR/2002/BA820 MA DCL
8 BA 69 MHOM/BR/1985/BA 69 BA LCL
9 BA 73 MHOM/BR/1985/BA 73 BA LCL
10 BA115 MHOM/BR/1987/BA115 BA LCL
11 BA125 MHOM/BR/1987/BA125 BA LCL
12 BA113 MHOM/BR/1987/BA113 BA LCL
13 M2269 MHOM/BR/1973/M2269 PA LCL
14 LV79 MPRO/BR/72M 1841-LV-79 BR LCL
(*) Code recommended for the Leishmania strain nomenclature, which includes
the following data: host, country of origin, year when it was isolated, and
original code (WHO, 1984).
doi:10.1371/journal.pone.0036595.t001
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after 2 h incubation at 37uC, 5% CO2. Promastigotes in stationary
phase were added to adherent macrophages, at a 3:1 ratio. After
2 h incubation at 34uC, free parasites were removed by extensive
washing with PBS and cultures proceeded for an additional 5, 24
or 72 h post-infection. Bone marrow macrophages were generated
as previously reported [18] and infected as described above. The
cultures were fixed in 100% methanol and stained with Giemsa
(Merck). The percentage of infected macrophages and the
infectivity index (percentage of infected macrophages x average
number of amastigotes per macrophage) were determined by
randomly counting at least 200 macrophages per slide in light
microscope, using the immersion objective (100X).
Parasite quantification by real-time PCR analysis of
parasite genomic DNA
As described in our previous report [19], parasite loads were
quantified by measuring the amount of L. amazonensis cysteine
proteinase isoform 1 (Llacys1) gene, which is a single-copy gene
per haploid genome and is expressed in both developmental
stages. Peritoneal macrophages from F1 mice were infected with
stationary-phase promastigotes for 24 and 72 h and genomic DNA
were extracted using a DNeasy kit (Qiagen). DNA (100 ng) was
used for parasite detection at the University of Texas Medical
Branch, the Real-time PCR Core Facility (all reagents were
purchased from Applied Biosystems). Each sample was run in
duplicate and normalized to the amount of total DNA extracted,
and the number of parasites per sample was calculated based on a
standard curve, as described in our previous studies [19].
Parasitophorous vacuole (PV) morphometry
The sizes of the infected macrophages PVs induced by different
isolates from patients with LCL and DCL were observed at
Olympus microscopy and images were acquired using the software
Image-Pro Plus 6.0 (Media Cybernetics). Values are shown as the
area, in mm
2, determined by width x length, for at least 60 PVs in
each tested isolate.
In vitro intracellular amastigote purification
Purification of intracellular amastigotes was performed using the
protocol adapted from Wanderley et al. [9]. Briefly, 3610
6
thioglycolate induced peritoneal or bone marrow macrophages
cultures were plated in 25-cm
2 bottles and infected with stationary-
phase promastigotes of L. amazonensis. After 24 h of infection, the
cultures were washed with 5 ml of PBS and 3 ml of lysis buffer
(20 mM Hepes, 0.25 M sucrose, 5 mM EDTA, 0.3 mM aproti-
nin, E-64 10 mM, Pepstatina 1 mM, pH 7.2) was added and
incubated for 5 min. After this period, the macrophages were
scraped from the bottle and lysed mechanically with a tissue
grinder. The cell suspension was centrifuged at 50 g for 5 min at
4uC. The supernatant was carefully removed, further centrifuged,
and washed two more times at 1450 g for 17 min at 4uC.
Amastigotes were incubated under rotation for 2 h in DMEM
(GIBCO) containing 4% FBS at 34uC to liberate the endocytic
membranes [9,20]. Parasites were centrifuged and washed 3 times
with PBS and kept on ice until use.
Flow cytometric analysis
The assessment of PS exposure was performed using the
protocol adapted from Wanderley et al. [9]. In summary, 2610
5
amastigotes forms were washed, suspended in Annexin V binding
buffer (ABB–10mM HEPES, 150 mM NaCl, 2.5 mM CaCl2) at
pH 7.2. Cells were incubated at room temperature for 15 min
with Annexin V-FITC (1/20 dilution; Molecular Probes) at the
concentration indicated by the manufacturer. At the moment of
acquisition, 0.4 mg/ml of propidium iodide (PI) was added to
control and Annexin V-FITC-labeled samples. Data is shown as
the difference between the geometric mean fluorescence intensity
of unstained control samples and annexin V stained ones (DMFI).
Data were collected in a BD FACScalibur and analyzed by
Cellquest Pro (BD Biosciences). At least five thousand gated events
were collected from each sample.
Table 2. Clinical and immunologic data from patients with diffuse cutaneous leishmaniasis (DCL) and localized cutaneous
leishmaniasis (LCL).
Lesions





(months) LST Nodules Ulcers Number
1 DCL M 23 60 Neg. ++++ 0 .500
2 DCL M 06 144 Neg. +++ 65 1
3 DCL M 20 180 Neg. +++ 01 6 8
4 DCL M 04 276 Neg. ++ 02 0
5 DCL F 07 180 Neg. +++ 01 4 0
6 DCL M 22 120 Neg. +++ + 68
7 DCL M 41 36 Neg. ++ 02 2
8L C L M 6 4 0 4 +32mm 2 + 8
9L C L M 5 4 0 1 +25mm 2 + 2
10 LCL M 70 02 +10mm 2 + 1
11 LCL F 08 03 +12mm 2 + 5
12 LCL M 27 06 +25mm 2 + 1
LST, Leishmanin Skin Test. –, no nodules; +, few; ++, moderate; +++, intense; ++++, very intense.
doi:10.1371/journal.pone.0036595.t002
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Macrophages were infected with different isolates of L.
amazonensis in serum-free medium. Infected macrophages were
treated with 100 ng/ml LPS from Escherichia coli, serotype 026:B6
(Sigma-Aldrich) for 20 h before collecting the supernatant for
cytokines assay. After acidification to activate latent TGF-b1
followed by neutralization, total TGF-b1 was measured in the
culture supernatants using ELISA according to the manufacturer’s
instructions (R&D Systems). Interleukin (IL)-10 and tumor
necrosis factor-alpha (TNF-a) levels were measured using de
Cytometric Bead Array Mouse Inflammatory kit (BD Biosciences)
according to the manufacturer’s protocol and analyzed by flow
cytometry. The concentrations of the TGF-b1, IL-10 and TNF-a
were determined by comparison with a curve generated from each
cytokine standard, respectively.
In vivo mouse infection
Six- to 8-wk-old wild-type and nude BALB/c mice were
infected in the footpad with 2x10
6 stationary-phase promastigotes
of L. amazonensis (LV79 strain). PS exposure on purified
amastigotes forms was evaluated weekly as previously described
[20]. The animals were euthanized, and the footpad was removed
under sterile conditions. The tissue was finely minced and
homogenized with a tissue grinder. The cell suspension was
ressuspended and centrifuged at 50 g for 10 min at 4uC. The
supernatant was carefully removed, further centrifuged, and
washed three more times at 1450 g for 17 min at 4uC. After 2-h
incubation under rotation at 34uC to liberate endocytic mem-
branes, the amastigotes were further centrifuged and incubated for
16 h at 34uC, at the end of which they were centrifuged and
washed three times before use. Mice representative of both groups
were sacrificed and histological analysis of infected tissues was
made. The images were observed at Olympus microscopy and
were acquired using the software Image-Pro Plus 6.0 (Media
Cybernetics).
Statistical analysis
Data are reported as median and interquartile interval of
representative experiments and were analyzed using GraphPad
Prism 5.0. Differences between groups were calculated using
Kruskal-Wallis with Dunn’s multiple comparison post test.
Unpaired t test was used to compare differences regarding
categorized variable. Mann-Whitney test was used to estimate
significance in IL-10/TNF-a and TGF-b/TNF-a ratios from LCL
or LCD macrophage infection. Spearman test was used to verify
the significance in the correlation tests. Each experiment was
repeated at least three times. Differences were considered
significant at p,0.05.
Results
Leishmania amazonensis amastigotes from DCL and LCL
patients expose different amounts of PS on their surface
Our group has shown that PS exposure on the external layer of
the amastigotes cell membrane is modulated by the host, being
higher on parasites recovered from BALB/c mice, compared with
parasites derived from C57BL/6 mice [9]. Based on these data, we
used F1 (BALB/c x C57BL6) mice to avoid the interference of the
host genetic background that could influence a possible modula-
tion of PS exposure. To check the amount of PS on L. amazonensis
amastigotes derived from DCL and LCL isolates, thioglycolate-
induced peritoneal macrophages from F1 mice were infected in
vitro with stationary-phase promastigotes. After macrophage
disruption, purified amastigotes were stained with Annexin V
and PI. We considered the gate annexin V
+/PI
- for PS exposure
analysis. As shown in Figure 1, at 24 h after infection, DCL-
derived amastigotes (BA106, BA276, BA336, BA700, and BA760)
presented higher levels of PS exposure (median 6 SD, DMFI of
28.963.9) than the LCL-derived parasites (BA69, BA73, BA115,
BA 125, and M2269) (DMFI of 10.762.6) (p=0.01). The
difference between the groups was no longer observed at 48 h
and remained unchanged until 72 h post-infection (data not
shown). Moreover, LV79, a long-term maintained L. amazonensis
strain in laboratory, showed PS exposure comparable to LCL
isolates. Independent assays were performed with all isolates
included in this study (table 1) and the same profile of PS exposure
was observed. Similar results were observed using bone marrow-
derived macrophages (data not shown). Therefore, the high levels
of PS exposure in parasite isolates from DCL patient group were
not specific to the source of macrophages.
Differential PS exposure modulates the infectivity of LCL
and DCL isolates
To rule out differences in metacyclogenesis we characterized the
percentage of metacyclics promastigotes in L. amazonensis isolates
from DCL and LCL patients as described by Saraiva et al. [21].
There were no differences regarding metacyclogenesis between
both groups (data not shown). To evaluate the infection profile of
the different LCL and DCL L. amazonensis isolates, we infected F1
peritoneal macrophages with stationary-phase promastigotes at a
3:1 parasite-to-cell ratio. The percentage of infected macrophages
(Figure 2A) and the infectivity index (Figure 2B) were similar at 5 h
Figure 1. PS exposure on the L. amazonensis amastigotes
surface. Thioglycollate-induced peritoneal macrophages derived from
F1 (BALB/C X C57BL/6) mice were infected with different isolates
obtained from patients with LCL (BA69, BA73, BA115, BA 125, and
M2269) (% ) and DCL (BA106, BA276, BA336, BA700, and BA760) (& )a t
a 3:1 parasite-to-cell ratio. After 24 h of infection, amastigotes were
purified for PS exposure analysis by flow-cytometry, as described in
Methods. One representative experiment of at least five independent
repeats is shown. Boxes represent median values and interquartile
interval from different isolates mentioned above. Differences were
checked using Unpaired t test.
doi:10.1371/journal.pone.0036595.g001
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internalization for both DCL (BA276, BA336, and BA700) and
LCL (BA69, BA73, BA 125, and M2269) parasites. However, the
percentage of infected macrophages was significantly higher at
72 h post-infection with DCL isolates (49%66.8) when compared
to LCL isolates (26%61.4, p=0.04). In addition, the infectivity
index of DCL parasites increased more than 2-fold, from 5 h (0.94
6 0.13) to 72 h post-infection (2.2160.85, p=0.01), while the
infectivity index of the LCL isolates was relatively constant,
indicating that proliferation of DCL isolates was more intense.
Quantitative PCR analysis of parasite loads at 24 and 72 h
confirmed that DCL isolates proliferated more efficiently than
LCL isolates (Figure 2C), corroborating results obtained by optical
microscopy (Figure 2B). To check whether differential PS exposure
by amastigotes observed at 24 h post-infection was related with
difference in infectivity among the isolates at 72 h post-infection,
we applied correlation statistics tests between these variables.
There was a positive correlation between PS exposure and the
percentage of infected macrophages (Figure 2D, r=0.756,
p=0.033) and infectivity index (Figure 2E, r=0.942, p=0.008),
suggesting that the differential PS exposure at 24 h might affect
the parasite load at 72 h.
Profile of cytokine production
To assess whether the infection with DCL or LCL L. amazonensis
isolates distinctly modulates the inflammatory activity of host cells,
we evaluated the levels of TGF-b1, TNF-a and IL-10 in the
supernatants of peritoneal macrophages infected with either DCL
(BA276, BA336, and BA700) or LCL (BA69, BA73, BA 125, and
M2269) isolates. We find significant difference between the two
groups regarding cytokine production for TNF-a at 24 h post-
infection (Figure 3C), but not for TGF-b1 (Figure 3A) and IL-10
(Figure 3B). Moreover, the ratio of TGF-b1/TNF-a (Figure 3D)
and of IL-10/TNF-a (Figure 3E) production were higher in DCL
than LCL isolates at 24 h post-infection. In fact, we found that PS
exposure on DCL amastigotes at 24 h post-infection displayed a
positive correlation with the TGF-b1/TNF-a ratio (Figure 3F,
r=0.75, p=0.03) and with the IL-10/TNF-a ratio (Figure 3G,
r=0.88, p=0.01), suggesting that the anti-inflammatory pheno-
type induced by macrophages infected with DCL isolates is linked
to PS exposure on the parasite surface.
PS exposure on the parasite surface is associated to PV
size
One of unique features of L. amazonensis infection is the
induction of large parasitophorous vacuoles (PVs) within infected
Figure 2. Leishmania isolate infectivity and PS exposure. Peritoneal macrophages derived from F1 mice were infected with different isolates
obtained from patients with LCL (BA69, BA73, BA 125, and M2269) (%) and DCL (BA276, BA336, and BA700) (&). After 5, 24 and 72 h of infection, cells
were fixed and stained. The percentage of infected macrophages (A) and infectivity index (B) were defined under a microscope. Parasite burden was
measured by quantitative PCR at 24 and 72 h (C). Boxes represent median values and interquartile interval from different isolates mentioned above.
The correlations between PS exposure at 24 h with percentage of infected macrophages and infectivity index in 72 h are showed in (D) and (E),
respectively. The four lower points in X axis (PS exposure) represents LCL isolates while the three higher points are from DCL isolates. One
representative experiment of at least three independent repeats is shown. Kruskal-Wallis was used with Dunn’s Multiple Comparison post-test.
Spearman test was used to verify the correlations. The r values are plotted in each graph.
doi:10.1371/journal.pone.0036595.g002
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to the capacity of the parasite to resist against macrophage
activation [24]. As shown in figure 4A, another marked difference
between DCL and LCL infection was the PV size. While DCL
infection induced large PVs, LCL infection showed tight vacuoles
at 72 h. There was no difference between groups relative to size of
the PVs at 4 and 24 h (data not shown). In order to quantify the
PV sizes induced by DCL (BA276, BA336, BA700) and LCL
Figure 3. Cytokine production by infected macrophages with different Leishmania amazonensis isolates. Peritoneal macrophages of F1
mice were infected with isolates obtained from LCL (BA69, BA73, BA 125, and M2269) (%) and DCL (BA276, BA336, and BA700) patients in a serum-
free medium containing 100 ng/ml LPS. Negative control (NC) represents uninfected macrophages. Supernatants were collected after 24 and 72 h
and active TGF-b1 (A) production was assayed by ELISA. IL- 10 (B) and TNF-a (C) production were assessed by Cytometric Bead Array (CBA). The TGF-
b/TNF-a (D) and IL-10/TNF-a (E) ratios. Boxes represent median values and interquartile interval of the ratios from different isolates mentioned above.
The correlations between PS exposure at 24 h with TGF-b/TNF-a and IL-10/TNF-a at 24 h are showed in (F) and (G), respectively. The four lower
points in X axis (PS exposure) represents LCL isolates while the three higher points are from DCL isolates. Differences were checked using Kruskal-
Wallis with Dunn’s multiple comparison post test. Spearman test was used to verify the significance in the correlations between cytokine ratio and PS
exposure. The r values are plotted in each correlation graph.
doi:10.1371/journal.pone.0036595.g003
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PV size of Giemsa-stained macrophages was determined by width
x length and presented as an averaged area (in mm
2). As shown in
Figure 4B, PV sizes induced by DCL isolates (346.4643.47) were
significantly higher than those induced by LCL isolates
(35.1265.48, p=0.0003). Furthermore, there was a highly positive
correlation between PV size and PS exposure on the parasite
surface. The DCL isolates displaying higher PS exposure at 24h of
infection, were also those inducing the largest vacuole sizes
(Figure 4C, r=0.942, p=0.016).
Based on evidences that PS exposure in amastigotes is induced
by the host immune response (Wanderley et al. manuscript in
preparation), we compared the intensity of PS exposure in L.
amazonensis (LV79) amastigotes obtained from Balb/c
nu/nu and
wild-type mice. Indeed, at 5–8 weeks post-infection, amastigotes
obtained from nude mice exposed 2–4 fold less PS at their surface
than did parasites obtained from wild-type counterparts
(Figure 4D). To characterize the role of PS exposure on PV
formation, we performed histological analysis of footpad lesions of
wild-type and nude mice. At 5 weeks post-infection, the majority
of infected macrophages observed in wild-type mice lesions
presented the characteristic large PVs; however, we could not
detect the occurrence of large PVs in nude mice, regardless of the
presence of a large number of parasites (Figure 4E). Moreover,
lesion-derived amastigotes purified from immune deficient mice (at
5 weeks post-infection) presented reduced infectivity index com-
pared with parasites derived from wild-type mice (Figure 4F).
PS exposure on L. amazonensis isolates correlates with
clinical disease
To check whether the differences in PS exposure found in
isolates from DCL (BA276, BA336, BA700 and BA760) and LCL
(BA69, BA73, BA 115, and BA125) patients could be associated
with different clinical parameters (Table 2), we performed
correlation statistics between these variables, using parasite PS
exposure at 24 h post-infection and clinical data, respectively.
These results showed that isolates which presented a higher PS
exposure on their surface, were derived from DCL patients with
the higher number of lesions (Figure 5A, r=0.928, p=0.002) and
duration of the disease (Figure 5B, r=0.994, p=0.004). These
data suggest that, in human DCL, parasites that are capable of
exposing higher amounts of PS induce a more severe and
persistent disease.
Discussion
The factors that determine DCL disease outcome remain poorly
understood and may be associated with immunological and
genetic features of the patients, as well as with pathogenic factors
of the parasite [2,3,25,26]. L. amazonensis is the main etiologic
Figure 4. Parasitophorous vacuole analysis. Photomicrographs of macrophages from F1 mice, infected with DCL (BA276) and LCL (BA125)
isolates after 72 h of culture (A). Arrows point to individual PVs. Magnification 400X. The average sizes of the PVs induced by different isolates from
patients with LCL (BA69, BA73 and BA 125) (%) and DCL (BA276, BA336, and BA700) (&) after 72 h of infection were measured using Image-Pro Plus
6.0 (B). Data are shown as the area in mm
2 of PVs in each tested isolate. Boxes represent median values and interquartile interval of PV sizes pooled
from different isolates mentioned above. The correlation between PS exposure at 24 h and PV area showed in (C). The three lower points in X axis (PS
exposure) represents LCL isolates while the three higher points are from DCL isolates. Differences were checked using unpaired t test. Spearman test
was used to verify the significance in the correlations between PV area and PS exposure. The r value is plotted in the correlation graph. PS exposure
on the L. amazonensis amastigotes surface from nude mice (Figures D–F). Mean fluorescence intensity of annexin V staining on lesion-derived
amastigotes (LV79) purified from BALB/c WT or BALB/c
nu/nu mice (D). Graph corresponds to one representative experiment out of three. H&E staining
of histological slides of infected footpads obtained from BALB/c WT or BALB/c nude mice 5 weeks post infection (E). Peritoneal macrophages derived
from BALB/c mice were infected with lesion-derived amastigotes (LV79) purified from BALB/c WT or BALB/c
nu/nu mice 5 weeks post infection. After
24 h of infection cells were fixed and stained. The infectivity index (F) was defined by microscopic analysis. Representative experiment of two repeats.
Differences were checked using unpaired t test.
doi:10.1371/journal.pone.0036595.g004
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with the entire spectrum of American cutaneous leishmaniasis
[2,27]. In the experimental models, L. amazonensis infection can
cause non-healing lesions in nearly all tested mouse strains, via
various mechanisms such as inhibition of antigen-presenting cell
functions, compromising the activation of effector lymphocytes
and exposure of PS on their surface in attempt to evade the
defense mechanisms of host cells [9,18,28-30].
Here we examined whether PS exposed on the surface of L.
amazonensis amastigotes obtained from DCL patients can operate
as a parasite pathogenic factor, repressing the host immune
response. We show, for the first time that, PS exposure by
amastigotes is associated with a modified host inflammatory
response, correlating with parasite infectivity and with clinical
parameters of DCL. We used L. amazonensis stocks isolated from
DCL or LCL patients to infect murine macrophages and assessed
PS exposure on the surface of purified intracellular amastigotes.
The observation of increased PS exposure in isolates from DCL
patients was consistently reproduced. The maintenance of the
capacity to expose PS indicates that this is a relatively stable
phenotype, controlled by unknown mechanisms. We showed that
parasites isolated from patients with DCL are able to expose more
PS moieties, in the first 24 h of interaction with murine
macrophages, when compared to amastigotes from LCL patients.
This difference on PS exposure correlates with parasite infectivity.
Indeed, those exposing high levels of PS on the surface, the DCL
isolates, had the higher percentage of infected cells at 72 h and the
ability to proliferate inside macrophages throughout the course of
infection. In this context, PS exposure in DCL isolates seemed to
be associated with parasite survival/persistence within the host
cell. The host cells used for the in vitro infection were (BALB/c x
C57BL/6) F1 macrophages, because PS exposure on amastigotes
is modulated depending on the host background [9]. This mice
strain displays a similar pattern of lesion development when
compared to C57BL/6 mice, with establishment of chronic
lesions, less severe than the ones observed in BABL/c mice [9].
Little is known about the inheritance patterns of resistance/
susceptibility loci, particularly for L. amazonensis infection. In other
models, the genetic predisposition for susceptibility or resistance in
mice correlates with gene loci that control the dominance of Th2
or Th1 responses, respectively [31]. Nevertheless this dichotomy
does not apply to the experimental models of L. amazonensis
infection.
Given that intense immune suppression is a hallmark of DCL
patients [32], it is conceivable that parasites with increased PS
exposure can contribute to disease suppression. The PS exposure
on Leishmania surface has been previously described by our group
as a strategy to infect and avoid host immunity, as well as for other
intracellular pathogens such as Trypanosoma cruzi [12] and
Toxoplasma gondii [11]. The results with L. amazonensis isolated
from DCL patients reinforce the PS recognition as a central event
inducing macrophage deactivation.
It is important to emphasize that parasite-associated factors,
other than PS, may also contribute to parasite survival/persistence
within the macrophage and to lesion exacerbation during the
course of human leishmaniasis. In this regard, L. amazonensis
isolated from patients with different forms of leishmaniasis showed
differences in resistance to NO, and patients infected with NO-
resistant isolates had significantly larger lesions than those infected
with NO-susceptible isolates [33]. Although this issue was not
addressed here, we cannot rule out a distinct resistance to NO
between isolates from DCL and LCL patients as a possible
explanation for the difference in parasite burden in infected
macrophages.
DCL patients with active disease show increased IL-10
expression in PBMCs [32]. Indeed, we observed that L. amazonensis
isolates from DCL patients preferentially induced an anti-
inflammatory profile of cytokines with a significant increase in
the IL-10/TNF-a ratio and were more competent to infect and
proliferate inside macrophages. These events were clearly corre-
lated with PS exposure on parasites. Several groups demonstrated
that L. amazonensis is able to deactivate intracellular pathways that
lead to innate immune cell activation, such as degradation or
decreased phosphorylation of STAT 1, 2, 3 and ERK1/2, reduced
expression of interferon regulatory factors 1 and 8, and activates a
classic transcriptional repressor, the p50/p50 NF-KB complex,
thereby reducing mRNA levels of iNOS [15,30]. In addition, the
expression of activation markers, MHC class II, cytokines and
chemokines is abrogated during the L. amazonensis infection
[29,34]. Nevertheless, it is important to notice that these
mechanisms were described for L. amazonensis strains maintained
in laboratory. Here we used parasites isolated from DCL and LCL
patients that might trigger different signaling pathways in parasite-
host cell interplay, but this hypothesis needs to be further
investigated.
A striking feature of the histological analysis of biopsies
performed in DCL patients is the presence of largely vacuolated
macrophages [2]. Interestingly, our in vitro results with DCL
isolates reproduced what is observed in patients. It was previously
demonstrated that large vacuoles formed by L. amazonensis
amastigotes are the result of macropinocytosis induced by the
parasite and are dependent on PS exposure [9]. Here, we showed
that differential PS exposure on parasites isolated from patients
with either DCL or LCL is associated with PV sizes. Although our
data suggest the involvement of PS molecule in the large vacuole
induction during L. amazonensis infection, we cannot discard the
possibility that other mechanisms are involved. The increased
expression of LYST/Beig, a gene related to the size of lysosomes
[35], and molecules secreted by the parasite into the vacuole [36]
may also contribute to the formation of vacuoles characteristic of
L. amazonensis infection. Albeit the mechanisms by which L.
amazonensis species manipulate the formation of large PVs are still
unclear, it has been suggested that PV expansion may protect L.
Figure 5. PS exposure on L. amazonensis isolates correlates with
clinical parameters of the disease. Correlation between clinical
parameters and PS exposure in isolates from DCL (BA276, BA336, BA700
and BA760) and LCL (BA69, BA73, BA 115, and BA125) at 24 h post-
infection. The four lower points in X axis (PS exposure) represents LCL
isolates while the four higher points are from DCL isolates. Spearman
test was used to verify the significance in the correlations between PS
exposure in 24 h with lesions number (A) and time of disease (B). The r
values are plotted in each correlation graph.
doi:10.1371/journal.pone.0036595.g005
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proteolytic enzymes present in the PV [24] and favoring parasite
replication within host cells [35]. Thus, it is possible that multiple
mechanisms may contribute to the formation/maintenance of
large PVs with heavy parasite loads in DCL lesions.
Previous studies from our group showed that PS exposure by
amastigotes is regulated by the host cells [9]. However, how the
host immune system participates in the modulation of parasite PS
exposure is not clear yet. Here we observed that parasites purified
from wild-type BALB/c mice footpad lesions exposed higher
amounts of PS than those purified from T cell-deficient BALB/
c
nu/nu mice. In addition, large vacuoles are present in wild-type
but not in nude mice, even though footpad lesions of immune-
deficient mice contained appreciable amounts of parasites.
Moreover, lesion-derived amastigotes purified from immune-
deficient mice presented reduced infectivity index compared with
wild-type mice strengthening the role of PS exposure for survival
and proliferation of intracellular parasites. Although these results
are not directly linked to DCL and LCL isolates, they reinforce the
importance of PS exposure in PV induction. On the other side,
our findings of differences in the PV areas suggest an association,
in a clinical setting, between enlarged PV size and immunodefi-
ciency. Actually, PS exposure on intracellular amastigotes seems to
be modulated by interactions between infected macrophages and
CD4
+ T cells (Wanderley et al., in preparation). In this regard, it is
possible that the low amounts of PS on amastigotes surface
displayed from nude mice are due to deficient T cell activation.
The diagnosis of DCL disease was validated by a set of clinical,
immunological, and histological parameters showing large PV
heavily parasitized. DCL patients had negative response to
leishmanin skin test, indicating the absence or low cell-mediated
response to parasite antigens, numerous lesions and a long period
of illness. Additionally, these patients also had numerous relapses
during treatment (Table 2). The greater number of lesions and a
longer duration of disease in DCL patients were associated with
increased PS expression in parasites isolated from these patients.
Therefore, it is also possible that recognition of PS by the host cells
increases macrophage permissiveness to parasite growth and
contributes to the maintenance of infection.
Despite that the PS exposure mechanism in L. amazonensis
amastigotes seems to be under the control of host adaptive
immune responses, whether or not these parasites acquire PS from
the host or from endogenous sources is still an open question.
Several lines of evidence strongly point to the active PS exposure
and rescue from apoptotic death as the most probable explanation
for the presence of PS
+ amastigotes. Our data suggest that
increased PS exposure on L. amazonensis isolated from patients with
DCL is an important and novel mechanism for parasite survival,
dissemination and disease outcome. However it is necessary to
gain insight into the mechanisms by which parasite PS exposure is
modulated in DCL patients. This understanding will be important
to extend our knowledge about the immunopathogenesis of DCL
disease and will open new perspectives for therapeutic interven-
tions.
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